This study is an evaluation of the dosing patterns of ustekinumab among patients with psoriasis in a real-world setting.
Qian Cai, MS, MSPH
Advertisement
Articles by Qian Cai, MS, MSPH
Patients with diabetic peripheral neuropathy taking L-methylfolate, pyridoxal-5'-phosphate, and methylcobalamin (MPM) had lower all-cause hospitalization risk and healthcare costs than patients not taking MPM.
Advertisement
Latest Updated Articles
- Impact of L-Methylfolate Combination Therapy Among Diabetic Peripheral Neuropathy Patients
Published: October 17th 2012 | Updated:
- Real-World Dosing and Utilization of Ustekinumab Among Patients With Psoriasis
Published: June 20th 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Biosimilar Stivant Shows Noninferior Efficacy and Comparable Safety to Reference Bevacizumab
3
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
4
Current and Emerging BCMAxCD3 Bispecifics
5
